Canada · Delayed Price · Currency is CAD Eupraxia Pharmaceuticals Statistics
Total Valuation
TSX:EPRX has a market cap or net worth of CAD 608.19 million. The enterprise value is 460.65 million.
| Market Cap | 608.19M |
| Enterprise Value | 460.65M |
Important Dates
The next estimated earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:EPRX has 65.33 million shares outstanding. The number of shares has increased by 47.78% in one year.
| Current Share Class | 65.33M |
| Shares Outstanding | 65.33M |
| Shares Change (YoY) | +47.78% |
| Shares Change (QoQ) | +16.77% |
| Owned by Insiders (%) | 15.68% |
| Owned by Institutions (%) | 36.24% |
| Float | 51.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.30 |
| P/TBV Ratio | 4.21 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 16.00, with a Debt / Equity ratio of 0.01.
| Current Ratio | 16.00 |
| Quick Ratio | 15.71 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.05 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -66.70% and return on invested capital (ROIC) is -46.80%.
| Return on Equity (ROE) | -66.70% |
| Return on Assets (ROA) | -43.66% |
| Return on Invested Capital (ROIC) | -46.80% |
| Return on Capital Employed (ROCE) | -43.47% |
| Weighted Average Cost of Capital (WACC) | 12.46% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 49 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSX:EPRX has paid 78,108 in taxes.
| Income Tax | 78,108 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.30% in the last 52 weeks. The beta is 1.50, so TSX:EPRX's price volatility has been higher than the market average.
| Beta (5Y) | 1.50 |
| 52-Week Price Change | +24.30% |
| 50-Day Moving Average | 9.02 |
| 200-Day Moving Average | 9.79 |
| Relative Strength Index (RSI) | 53.15 |
| Average Volume (20 Days) | 55,537 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -81.10M |
| Pretax Income | -71.27M |
| Net Income | -73.11M |
| EBITDA | -80.64M |
| EBIT | -81.10M |
| Earnings Per Share (EPS) | -1.42 |
Balance Sheet
The company has 189.81 million in cash and 2.62 million in debt, with a net cash position of 187.19 million or 2.87 per share.
| Cash & Cash Equivalents | 189.81M |
| Total Debt | 2.62M |
| Net Cash | 187.19M |
| Net Cash Per Share | 2.87 |
| Equity (Book Value) | 184.15M |
| Book Value Per Share | 2.21 |
| Working Capital | 182.13M |
Cash Flow
In the last 12 months, operating cash flow was -53.22 million and capital expenditures -1.07 million, giving a free cash flow of -54.29 million.
| Operating Cash Flow | -53.22M |
| Capital Expenditures | -1.07M |
| Depreciation & Amortization | 450,064 |
| Net Borrowing | n/a |
| Free Cash Flow | -54.29M |
| FCF Per Share | -0.83 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:EPRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -47.78% |
| Shareholder Yield | -47.78% |
| Earnings Yield | -12.02% |
| FCF Yield | -8.93% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for TSX:EPRX is 16.00, which is 71.86% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 16.00 |
| Price Target Difference | 71.86% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |